5α‐reductase isozymes and aromatase are differentially expressed and active in the androgen‐independent human prostate cancer cell lines DU145 and PC3

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Prostate

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0045(19991201)41:4<224::AID-PROS2>3.0.CO;2-QPMID 10544295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Role for Estrogen in Cancer?

  1998cited by this paper
• Presence of 5α‐Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue

  1998cited by this paper
• Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines

  1997cited by this paper
• Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period

  1997cited by this paper
• Differential gene expression of steroid 5 alpha-reductase 2 in core needle biopsies from malignant and benign prostatic tissue.

  1997cited by this paper
• Product of aromatase activity in intact LNCaP and MCF-7 human cancer cells.

  1997cited by this paper
• Aromatase in hyperplasia and carcinoma of the human prostate

  1997cited by this paper
• Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.

  1997cited by this paper
• Estradiol activates p60src, p53/56lyn and renatured p50/55 protein tyrosine kinases in the dog prostate.

  1997cited by this paper
• Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin.

  1996cited by this paper
• 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro.

  1996cited by this paper
• Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells

  1996cited by this paper
• Aromatase mRNA Levels in Benign Prostatic Hyperplasia and Prostate Cancer

  1996cited by this paper
• The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.

  1996cited by this paper
• Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.

  1996cited by this paper
• Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.

  1996cited by this paper
• Differential expression of 5α‐reductase isoenzymes in the human prostate and prostatic carcinomas

  1996cited by this paper
• Growth inhibition of androgen‐insensitive human prostate carcinoma cells by a 19‐norsteroid derivative agent, mifepristone

  1995cited by this paper
• Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.

  1995cited by this paper
• Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.

  1995cited by this paper
• Functional ovarian and placental isoforms of porcine aromatase.

  1995cited by this paper
• Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DUI45, and LNCap prostatic cancer cell lines: Relationship with DNA ploidy level

  1995cited by this paper
• Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease.

  1994cited by this paper
• Steroid 5 alpha-reductase: two genes/two enzymes.

  1994cited by this paper
• Androgen metabolism in the human prostatic cancer cell line LNCaP.

  1994cited by this paper
• Inhibition of the activity of basic 5α-reductase (type 1) detected in DU 145 cells and expressed in insect cells

  1994cited by this paper
• Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells.

  1994cited by this paper
• Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.

  1994cited by this paper
• Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells.

  1994cited by this paper
• Sex hormones and antihormones in endocine dependent pathology : basic and clinical aspects : proceedings of an international symposium, Milano, 10-14 April 1994

  1994cited by this paper
• Expression and regulation of steroid 5α-reductase 2 in prostate disease

  1994cited by this paper
• Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.

  1993cited by this paper
• DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

  1993cited by this paper
• Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  1993cited by this paper
• Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes.

  1993cited by this paper
• Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

  1992cited by this paper
• Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.

  1992cited by this paper
• Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases.

  1990cited by this paper
• Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.

  1984cited by this paper
• Diurnal variation in the inducibility of luteal 20 alpha-hydroxysteroid dehydrogenase in pregnant rats.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Differential Gene Expression of Steroid 5�-Reductase 2 in Core Needle Biopsies from Malignant and Benign

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Different 17�-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*

  year unknowncited by this paper

• Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro

  2021cites this paper
• Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system.

  2020cites this paper
• Effects of testosterone and 17β‑estradiol on angiotensin‑induced changes in tyrosine kinase activity in the androgen‑independent human prostate cancer cell line, DU145.

  2017cites this paper
• Chapter 7 Neem and Prostate Cancer Therapy

  2016cites this paper
• Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome

  2016cites this paper
• Bone Metastases

  2014cites this paper
• Systemic Therapy of Bone Metastases

  2014cites this paper
• Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.

  2014cites this paper
• Progesterone restores the female prostate activity in ovariectomized gerbil and may act as competitor of testosterone in intraprostatic environment.

  2013cites this paper
• Novel Molecular Targets of Azadirachta indica Associated with Inhibition of Tumor Growth in Prostate Cancer

  2011cites this paper
• Aromatase and regulating the estrogen:androgen ratio in the prostate gland.

  2010cites this paper
• Molecular cell biology of androgen receptor signalling.

  2010cites this paper
• Androgens inhibit androgen receptor promoter activation in motor neurons.

  2009cites this paper
• Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5‐alpha reductase and aromatase in gerbil ventral prostate

  2009cites this paper
• Hormonotherapy of Bone Metastases

  2009cites this paper
• 5α-Reductase inhibitor treatment of prostatic diseases: background and practical implications

  2009cites this paper
• Androgen regulation of axon growth and neurite extension in motoneurons.

  2008cites this paper
• Estrogen-regulated development and differentiation of the prostate.

  2008cites this paper
• Differential Expression of Genes Related to Androgen and Estrogen Metabolism in Hereditary versus Sporadic Prostate Cancer

  2008cites this paper
• Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

  2007cites this paper
• Testosterone, estradiol and aromatase inhibitor therapy in elderly men.

  2007cites this paper
• Benign prostatic hyperplasia ( BPH ) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E 2

  2007cites this paper
• Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.

  2006cites this paper
• Reductase Activity of 17β-Hydroxysteroid Oxidoreductase in Prostatic Tumors of Different Histological Structure

  2005cites this paper
• Acquisition of Androgen Independence by Human Prostate Epithelial Cells during Arsenic-Induced Malignant Transformation

  2005cites this paper
• Expression of prostate specific membrane antigen in androgen-independent prostate cancer cell line PC-3.

  2005cites this paper
• Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells

  2005influential citation
• Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.

  2005cites this paper
• The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.

  2005cites this paper
• Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1.

  2005cites this paper
• Regulation of aromatase and 5α-reductase by 25-hydroxyvitamin D3, 1α,25-dihydroxyvitamin D3, dexamethasone and progesterone in prostate cancer cells

  2005cites this paper
• Vitamin D 3 metabolism in normal and malignant human prostate cells

  2005cites this paper
• The Androgen Derivative 5 A -Androstane-3 B ,17 B -Diol Inhibits Prostate Cancer Cell Migration Through Activation of the Estrogen Receptor B Subtype

  2005cites this paper
• Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft

  2004cites this paper
• Lycopene: modes of action to promote prostate health.

  2004cites this paper
• Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.

  2004cites this paper
• Local aromatase expression in human prostate is altered in malignancy.

  2004cites this paper
• Selective non-steroidal inhibitors of 5 alpha-reductase type 1.

  2004cites this paper
• Selective non-steroidal inhibitors of 5α-reductase type 1

  2004cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer Oestrogens and prostate cancer

  2003cites this paper
• Exemestane seems to stimulate tumour growth in men with prostate carcinoma.

  2003cites this paper
• Oestrogens and prostate cancer.

  2003cites this paper
• Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor.

  2003cites this paper
• CHAPTER 347 – Prostate

  2003cites this paper
• Direct response of the murine prostate gland and seminal vesicles to estradiol.

  2002cites this paper
• The Role of 5α-Reductase in Prostate Disease and Male Pattern Baldness

  2002cites this paper
• Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.

  2002cites this paper
• A Randomized , Double-Blind , Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5 AR in the Treatment of Androgenetic Alopecia

  2002cites this paper
• Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures.

  2002cites this paper
• A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.

  2002cites this paper
• Factors affecting oestrogen action in the human prostate : does 5α-reductase type 1 isozyme have a role?

  2002cites this paper
• 5alpha-reductase activity in the prostate.

  2001cites this paper
• 5α-reductase activity in the prostate

  2001cites this paper
• Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats.

  2001cites this paper
• Voiding dysfunction and female urology

  1997cites this paper